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Abstract Using the yeast two-hybrid system, we studied the
physical interaction between the complete C1 and C2 cytosolic
domains of Xenopus laevis type 9 (xl9C1, xl9C2) and the C2
domain of rat type 6 (r6C2) adenylyl cyclase (AC). Hetero-
dimerization between xl9C1 and xl9C2 and homodimerization
between C2 (but not C1) domains was observed. Interaction
between C2 and human GKs (hGKs) was also detected and was
dependent on GKs activation. In contrast X. laevis GKs (xlGKs),
which is 92% identical to hGKs, was unable to interact with any
of the three AC cytosolic domains tested, corroborating previous
findings that showed no effector activation. Through the
construction of chimeras, we demonstrated that the amino-
terminal half of xlGKs was responsible for the lack of interaction
with AC. Chimeras between mouse GKi2 and GKs (N-mGKi2/C-
GKs), that have previously shown to activate AC to a higher
extent than wild-type GKs, also interacted with the C2 cytosolic
domain and with a higher affinity. Interestingly, N-mGKi2/C-
xlGKs chimera was not only able to interact with C2 but also
with the C1 cytosolic domain.
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1. Introduction
Adenylyl cyclase (AC) is a widely distributed G protein
coupled receptor (GPCR) regulated e¡ector system which cat-
alyzes the synthesis of cAMP, a ubiquitous second messenger
that mediates diverse cellular responses by activating cAMP-
dependent protein kinases. To date, nine di¡erent mammalian
isoforms have been cloned and characterized from di¡erent
sources [1^3]. AC isoenzymes di¡er in their tissue distribution
and regulatory properties. With the exception of AC type 9,
all of them are stimulated by the active GTP-bound form of
GKs and the diterpene forskolin (Fk) [3^7]. Almost all AC
(except type 4) are regulated directly or indirectly by Ca2
[3,8,9]. Types 1, 3 and 8 are activated by Ca2-calmodulin,
types 5 and 6 are inhibited by Ca2 levels and types 2 and 5
are activated by protein kinases A and C (PKA, PKC) [10^
14]. GLQ heterodimers also modulate the activity of some AC
isoforms, activating AC types 2 and 4 and inhibiting type 1
[15^17].
All known mammalian AC isozymes share a predicted
topological structure designated as NM1C1M2C2, containing
a short amino-terminal region (N), two highly hydrophobic
domains (M1 and M2) that are postulated to contain six trans-
membrane helixes, and two cytoplasmic domains (C1 and C2).
The amino-terminal halves of each cytoplasmic domain (C1a
and C2a) share a high homology and are 50^90% similar to
the corresponding domains of other AC isoforms and only
20^25% similar to the catalytic domains of guanylyl cyclases
[3,18]. Recently, expression of a soluble form of a mammalian
AC has been achieved, allowing for important biochemical
and structural studies of the enzyme [19,20]. When the C1a
domain of AC type 1 and the C2 domain of AC type 2 iso-
forms (joined by a small linker) were expressed, a soluble and
active enzyme was obtained. This enzyme was activated by
GTP-GKs and Fk, and inhibited by P-site inhibitors and
GLQ dimers. Expression of the individual domains (C1 or
C2) exhibited little or no enzymatic activity [20,21]. Interest-
ingly, coexpression of the two AC cytosolic domains as sep-
arate entities showed enzymatic activity and regulatory prop-
erties of the native enzyme, indicating that non-covalent
interactions between C1 and C2 are important for catalytic
activity [22,23]. Consistent with this idea, crystallographic
studies performed by di¡erent groups have shown that frag-
ments of both soluble AC cytosolic domains can interact in
the presence of Fk, and that only C2 can form homodimers
and physically interact with GKs [24^27]. By using the two-
hybrid system, Scholich et al. [28] have identi¢ed a 10-amino
acid (aa) region within the C2 domain in AC type 5 that was
able to interact with a 112-aa peptide of C1b and showed that
this interaction was modulating the stimulation by GKs.
Recently, we reported the cloning and characterization of a
X. laevis type 9 AC [29], which is activated by the human
GKs, but not by its homologous xlGKs, even though both
proteins share 92% of identity [30]. In order to try to under-
stand this di¡erence, we have evaluated the direct intermolec-
ular interaction between the human and Xenopus GKs and the
AC cytosolic domains C1 and C2. Using the yeast two-hybrid
system we show that only the activated form of the hGKs, but
not the xlGKs, was able to interact with the C2 domain of the
enzyme. This is in agreement with the lack of activation of AC
by the Xenopus GKs subunit, that we had previously reported
[30].
2. Materials and methods
2.1. Plasmids construction for the yeast two-hybrid system
Yeast cloning vectors containing the Gal4 DNA-binding domain
(pAS2-1) and the GAL4 activating domain (pACT2) were obtained
from Clontech. cDNAs containing the entire coding sequence of
xlGKs, xlGKs(Q/L), hGKs, and hGKs(Q/L) were excised from their
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respective recombinant vectors with NcoI and SalI and inserted in-
frame into pAS2-1. Chimera 10 (ch10) was constructed by ligation of
a mouse GKi2 NcoI-Tth111I cDNA fragment (aa 1^193) to a human
GKs Tth111I-SalI cDNA fragment (aa 201^379) and subcloned into
pAS2-1 vector. ch10(Q/L) was obtained the same way as ch10, but
using the human GKs(Q/L) Tth111I-SalI cDNA fragment. Chimera 9
(ch9) and ch9(Q/L) were synthesized as ch10 and ch10(QL) by using
the xlGKs Tth111I-SalI or the xlGKs(Q/L) Tth111I-SalI cDNA frag-
ments. Chimera 2 (ch2) was originated by ligation of an hGKs(Q/L)
NcoI-BglII fragment (aa 1^280) to a xlGKs BglII-SalI fragment (aa
281^379) and subcloned into the pAS2-1 vector. Chimera 1 (ch1) was
constructed by ligation of an xlGKs(Q/L) NcoI-BglII fragment (aa 1^
280) to an hGKs BglII-SalI fragment (aa 281^379) and subcloned into
the pAS2-1 vector. AC C1 and C2 domains were ampli¢ed by PCR
using the X. laevis AC type 9 (xlAC9) and rat AC type 6 (rAC6) full-
length cDNAs as template. The following oligonucleotides were used
for the ampli¢cation of the di¡erent AC fragments: xlAC9C1 (aa 346^
832), forward primer containing an NcoI site 5P-CTTTTCAC-
CATGGCTGAGGTCCGA-3P and a reverse primer containing a
BamHI site 5P-AAGGAGTGGATCCTGCAAGGA-3P ; xlAC9C2 (aa
1037^1355), forward primer containing a BamHI site 5P-CTGGT-
GTGGATCCTGAACCGT-3P and a reverse primer containing an
EcoRI site 5P-GATCCGAATTCTGCCTCACCG-3P ; rAC6C2 (aa
911^1135), forward primer containing a BamHI site 5P-TATCTACG-
GATCCAACAGGTG-3P and a reverse primer with an EcoRI site 5P-
CACTGCTGGAATTCGCTAACTGCT-3P. After digestion with the
appropriate restriction enzymes, the PCR fragments were subcloned
into the pACT2 vector. The same NcoI-BamHI xlAC9C1 PCR frag-
ment was subcloned into pAS2-1, but PCR fragments xlAC9C2 and
rAC6C2 were ¢rst subcloned into the pCEV-29 vector, then excised
with BamHI and SalI, and ¢nally subcloned into the pAS2-1 vector.
All constructs were sequenced to con¢rm the correct reading frames
and fusion protein expression was analyzed by Western blot using
speci¢c antibodies against GAL4 activating domain, GAL4 DNA-
binding domain and GKs (from Santa Cruz) (data not shown).
2.2. Two-hybrid assay
The yeast two-hybrid assay was performed using the Y190 yeast
strain (from Clontech), which was transformed with the appropriate
plasmids, using the lithium acetate procedure and grown on SD plates
in the absence of Trp and Leu. Protein interaction analysis was
performed on SD plates without Leu, Trp and His (SD/
Leu3,Trp3,His3). After 3 days at 30‡C, individual colonies were
straked out and grown on SD/Leu3,Trp3 liquid medium and tested
for L-galactosidase activity.
2.3. Quantitative L-galactosidase assay
Liquid culture assay for L-galactosidase was performed according
to the instructions from the ‘Luminescent L-gal Genetic Reporter
System II’ kit (from Clontech). Data for quantitative assays were
corrected for yeast cell number and are the mean þ S.E.M. of triplicate
assays.
3. Results
In order to study the physical interaction between the AC
cytosolic domains, we subcloned the full-length fragments that
codify for C1 and C2 of xlAC9 and for C2 of rAC6 into
appropriate two-hybrid system vectors (Fig. 1). After trans-
formation of the Y190 yeast cells with the corresponding re-
combinant plasmids, L-galactosidase activity was measured.
As shown in Fig. 2, a very strong interaction between C2
domains was observed, the highest occurring between homol-
ogous domains (rC2-rC2 and xlC2-xlC2). The C1 domain, on
the contrary, showed no L-galactosidase activity stimulation
thus indicating no homodimerization between these cytosolic
domains. As expected, heterodimerization between the C1 and
C2 xlAC cytosolic domains was also detected.
After proving by Western analysis that the AC cytosolic
domains were expressed (data not shown) and able to interact
in our two-hybrid system, we continued to look at their in-
teraction with GKs. To perform this assay, we used the wild
type and constitutively activated Q212/L mutant of the short
form of hGKs and xlGKs. Interaction with the C2 domain was
observed, when the hGKs was tested, and this association was
dependent on the activated state of the K subunit (Fig. 3). No
interaction with C1 was detected, con¢rming previous crystal-
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Fig. 1. Schematic representation of the constructions used in the yeast two-hybrid system analysis. Letters above each diagram represent the re-
striction enzymes utilized to subclone the di¡erent PCR ampli¢ed cDNAs into pACT2 and pAS2-1 vectors. B = BamHI, Bg = BglI, E = EcoRI,
N = NcoI, S = SalI, T = Tth111I. Letters and numbers below indicate the amino acid and its corresponding position in the cDNA, respectively.
pAS1-ch1(Q/L) and pAS1-ch2(Q/L) correspond to pAS-ch1 and pAS-ch2 constructions with the Q212L mutation in the GKs region. P53 and
SV40Tag were used as a positive two-hybrid system control.
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lographic and biochemical studies performed with puri¢ed AC
cytosolic fragments [19^23]. With the xlGKs, on the contrary,
neither the wild type nor the activated mutant were able to
interact with any of the cytosolic domains (data not shown).
This result is in agreement with our previous ¢ndings which
showed that the xlK subunit was not able to activate the S49
cyc3 AC in an ‘in vitro’ reconstituted system [30]. In that
study we demonstrated, by the construction of chimeras be-
tween human and Xenopus GKs, that a region within the N-
terminal half, which constitutes the helical domain of the pro-
tein, was responsible for the lack of activation [30]. For this
reason, we decided to test out the constitutively activated (Q/
L) chimeric proteins for their physical interaction with the
xlAC cytosolic domains. When coexpressed with the C2 do-
main, ch2 (N-hGKs/C-xlGKs) but not ch1 (N-xlGKs/C-hGKs)
was able to stimulate the L-galactosidase reporter gene (Fig.
4), con¢rming the inability of ch1 to activate AC. In addition,
since GKi/GKs chimeras were shown to activate AC to a high-
er extent than wild-type GKs [31^34], we decided to also test
them in the two-hybrid assay. As shown in Fig. 5, both Q/L
mutated chimeras (ch9 and ch10) were not only able to inter-
act with C2, but also with a substantially higher a⁄nity (com-
pare Fig. 3 with Fig. 5), con¢rming the AC activation studies
mentioned above. Surprisingly, ch9 (N-mGKi2/C-xlGKs) but
not ch10 (N-mGKi2/C-hGKs) was able to interact very
strongly with the C1 AC cytosolic domain.
4. Discussion
We have expressed the full-length AC cytosolic domains C1
and C2 fused to the GAL4-DNA binding or activating do-
mains and tested ‘in vivo’ for their capacity to interact. Pro-
tein-protein interaction was quantitated by measuring L-ga-
lactosidase activity with a highly sensitive chemiluminescent
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Fig. 2. Interaction of C1 and C2 domains of xl9AC and r6AC.
Y190 were co-transformed with the indicated cDNA fragments
subcloned in the two-hybrid vectors written on the left side of the
¢gure. Transformants were grown in synthetic SD liquid medium
without leucine and tryptophan at 30‡C for three days and L-galac-
tosidase activity was measured as described in Section 2.
Fig. 3. Interaction of AC C1 and C2 domains with wild-type hGKs
and mutant GKs(Q/L). Experimental conditions are similar to those
described in Fig. 2.
Fig. 4. Interaction of AC C1 and C2 domains of AC with GKs chi-
meras ch1, ch1(Q/L), ch2 and ch2(Q/L). Experimental conditions
are similar to those described in Fig. 2.
Fig. 5. Interaction of AC C1 and C2 domains of AC GKs with
GKi-GKs chimeras. Chimera 9 and chimera 10 were constructed as
indicated in Fig. 1 and co-transformed in Y190 with AC C1 or C2
domains as indicated in the bottom of the ¢gure. Experimental con-
ditions are similar to those described in Fig. 2.
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assay. The two-hybrid system employed in this study has the
advantage of allowing us to di¡erentiate between homologous
or heterologous interactions and also to estimate the relative
interaction a⁄nities that are proportional to the L-galactosi-
dase activity.
Our results show that the full-length C2 cytosolic domain of
xlAC9 was able to homodimerize very strongly (similar to p53
with SV40TAg) and also to heterodimerize with a lower af-
¢nity to the C1 domain of the same AC. This ¢nding corrob-
orates previous biochemical and crystallographic studies per-
formed with fragments of C1 and C2 domains of heterologous
AC [19^23]. Unfortunately, with the two-hybrid system used
in this study, we were unable to look at the e¡ect of Fk or
GKs on C1-C2 interaction that has been previously reported to
substantially increase their a⁄nity [26]. The xlAC9-C1 do-
main, on the contrary, showed no capacity to homodimerize
which contradicts the experiments reported by Sunahara et al.
[26] performed with gel ¢ltration, where it was shown that
both cytosolic fragments were eluting as dimers. We believe
that the reason for this discrepancy is the di¡erence in size of
the AC domains. In our study we used the complete C1 cy-
tosolic domains that is 486 aa long, whereas Sunahara et al.
expressed only a fragment of it, that is half the size (227 aa) of
the whole domain.
Using the same approach, we were also able to measure a
weak interaction between the hGKs(Q/L) and the C2 domain,
but no interaction with C1. This ¢nding is also in good agree-
ment with crystallographic data, which showed that GKs was
predominantly interacting with C2 [27]. In addition, gel ¢ltra-
tion and equilibrium sedimentation studies also corroborated
the same results as well as the requirement of GKs to be in an
active conformation in order to interact with C2. On the other
hand, the lack of interaction observed with the xlGKs again
corroborates and explains the inability of this K subunit to
activate AC. We now believe, based on trypsin protection
experiments (unpublished results), that the reason for this
anomalous behavior is due to the incapacity of this protein
to adopt the active conformation state necessary to interact
with C2 and to activate AC.
Interaction studies performed with GKi/GKs chimeras, that
have previously shown to be better activators of AC than
wild-type GKs, con¢rm these results. Since the hybrid chimer-
ic proteins showed a considerably stronger interaction with C2
than the normal GKs, this possibly indicates that these pro-
teins tend to have a more permanent activated conformation.
Based on the pseudosimetric structure adopted by the C1-
C2 heterodimer and to the simultaneous activating and inhib-
itory e¡ect produced by GKs and GKi on AC, Tesmer et al.
[27] have proposed a GKi interaction site in C1 equivalent to
the GKs binding site in C2. This hypothesis has now been
con¢rmed by demonstrating the formation of a stable com-
plex between GTPQS-GKi and the C1 (but not C2) domain of
type 5 AC [35]. Now that a C1-GKi interaction has been
proven, we can better understand the behavior of ch9 which
showed the capacity to interact with C2 and C1. Since ch9 is a
hybrid between GKi and GKs it is possible to speculate that
the chimeric protein could adopt a conformation capable of
binding to both domains. We do not know the reason why
ch10 does not interact with C1, and further analyses are
needed in order to understand these di¡erences.
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